The Effects of Different Exercise Modalities in Adolescents With Type 1 Diabetes Using AID Systems (MODE2022)
Type 1 Diabetes
About this trial
This is an interventional prevention trial for Type 1 Diabetes
Eligibility Criteria
Inclusion Criteria: Age 13-17 years old Type 1 diabetes > 1 year Use of Tandem t:slim X2 Control-IQ or Medtronic MiniMed 780G with connected continous glucose monitor > 3 months HbA1c below 75 mmol/L Exclusion Criteria: Use of anti-diabetic medicine other than insulin Breastfeeding, pregnancy or planning to become pregnant Lack of compliance with key study procedures at the discretion of the investigator
Sites / Locations
- Steno Diabetes Center CopenhagenRecruiting
Arms of the Study
Arm 1
Arm 2
Active Comparator
Active Comparator
High Intensity Interval Exercise
Moderate Intensity Continous Exercise
Plasma and sensor glucose is monitored before, during and after a bout of high intensity interval exercise
Plasma and sensor glucose is monitored before, during and after a bout of moderate intensity continous exercise